GTC Biotherapeutics Collaborates With LFB Biotechnologies

GTC Biotherapeutics (Framingham, MA, http://www.gtc-bio.com) and LFB Biotechnologies (France) have signed an agreement to collaborate in the development of selected recombinant plasma proteins and monoclonal antibodies using GTC’s transgenic production platform. A joint steering committee will agree on product development and commercialization plans.